Verition Fund Management
AVNR

Verition Fund Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Verition Fund Management’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-703,900
Closed -$11.9M – 592
2014
Q4 		$11.9M Buy
+703,900
New +$9.9M 2.67% 6

Verition Fund Management's AVNR Position: Q4 2013 in Review

Verition Fund Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2013, closing a stake of 13,419 shares — an estimated $57K sold.

Verition Fund Management first reported a position in AVNR in Q3 2013 and held it in 1 quarter. The position peaked at $57K in Q3 2013. 101 funds tracked by Wall St. Rank hold AVNR as of Q4 2013.

  • Verition Fund Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2013 after selling out during the quarter.
  • Verition Fund Management sold 13,419 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2013, an estimated $57K.
  • Verition Fund Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 1 quarter.
  • Verition Fund Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $57K in Q3 2013.
  • 101 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2013.

Based on Verition Fund Management's 13F filing for Q4 2013, filed 14 Feb 2014.